Stay updated on High CRC/Pancreatic Clinical Trial
Sign up to get notified when there's something new on the High CRC/Pancreatic Clinical Trial page.

Latest updates to the High CRC/Pancreatic Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 with no visible changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedUI updates on the study page include showing the glossary, updating QC-related labels (Last Update Submitted that Met QC Criteria), and changing the revision tag to v3.4.0, while removing older labels such as No FEAR Act data and Last Update Submitted that met QC Criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedJulie Koenig, MD is now listed as the responsible party at Massachusetts General Hospital (Boston, MA 02114), replacing Theodore Hong, MD. The update also includes a new last update date and Revision: v3.3.4.SummaryDifference0.8%

- Check47 days agoChange DetectedAdded a dedicated Locations section with Massachusetts listed as a study site. The footer was updated to Revision v3.3.3, and the standalone Massachusetts Locations entry and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check75 days agoChange DetectedEditorial wording in the Publications section was updated to clarify that publications are automatically filled from PubMed. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check83 days agoChange DetectedThe government funding lapse notice at the top of the page was removed. The study details themselves appear unchanged.SummaryDifference0.4%

Stay in the know with updates to High CRC/Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High CRC/Pancreatic Clinical Trial page.